Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma

Clinical trial NCT03150160 · COMPLETED

Trial details

NCT number

NCT03150160

Sponsor

Novartis Pharmaceuticals

Status

COMPLETED

Phase

Phase 4

Study type

INTERVENTIONAL

Start date

2017-09-21

Primary completion

2017-12-04

Enrollment

1

View on ClinicalTrials.gov